MYLAN 6201 MYLAN 6201 (Verapamil ER 100 mg)
Pill imprint MYLAN 6201 MYLAN 6201 has been identified as Verapamil hydrochloride extended release 100 mg.
Verapamil is used in the treatment of migraine prevention; cluster headaches; high blood pressure; bipolar disorder; arrhythmia (and more), and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Verapamil 100 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 100 mg
- Red & White
- 18.00 mm
- Prescription only
Group IV antiarrhythmics
methacrylic acid - methyl methacrylate copolymer (1:1)
methacrylic acid - methyl methacrylate copolymer (1:2)
sodium lauryl sulfate
D&C Red No. 28
D&C Red No. 33
D&C Yellow No. 10
FD&C Red No. 40
FD&C Blue No. 1
FD&C Blue No. 2
More about verapamil
- Verapamil immediate-release
- Verapamil immediate-release tablets
- Verapamil long-acting tablets
- Verapamil sustained-release capsules controlled onset
- More (4) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.